- Home
- PETZ vs BGLC Comparison
PETZ vs BGLC Comparison
Compare PETZ & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PETZ
- BGLC
- Stock Information
- Founded
- PETZ 2002
- BGLC 2017
- Country
- PETZ China
- BGLC Malaysia
- Employees
- PETZ N/A
- BGLC N/A
- Industry
- PETZ Steel/Iron Ore
- BGLC Medical Specialities
- Sector
- PETZ Industrials
- BGLC Health Care
- Exchange
- PETZ Nasdaq
- BGLC Nasdaq
- Market Cap
- PETZ 9.3M
- BGLC 10.7M
- IPO Year
- PETZ 2017
- BGLC N/A
- Fundamental
- Price
- PETZ $0.99
- BGLC $5.14
- Analyst Decision
- PETZ
- BGLC
- Analyst Count
- PETZ 0
- BGLC 0
- Target Price
- PETZ N/A
- BGLC N/A
- AVG Volume (30 Days)
- PETZ 5.9K
- BGLC 3.1M
- Earning Date
- PETZ 04-28-2025
- BGLC 08-13-2025
- Dividend Yield
- PETZ N/A
- BGLC N/A
- EPS Growth
- PETZ N/A
- BGLC N/A
- EPS
- PETZ 0.26
- BGLC N/A
- Revenue
- PETZ $563,726.00
- BGLC $9,265,870.00
- Revenue This Year
- PETZ N/A
- BGLC N/A
- Revenue Next Year
- PETZ N/A
- BGLC N/A
- P/E Ratio
- PETZ $5.09
- BGLC N/A
- Revenue Growth
- PETZ 74664.72
- BGLC N/A
- 52 Week Low
- PETZ $0.65
- BGLC $2.01
- 52 Week High
- PETZ $1.74
- BGLC $15.60
- Technical
- Relative Strength Index (RSI)
- PETZ 53.95
- BGLC 55.54
- Support Level
- PETZ $0.95
- BGLC $3.57
- Resistance Level
- PETZ $1.10
- BGLC $7.05
- Average True Range (ATR)
- PETZ 0.07
- BGLC 1.44
- MACD
- PETZ 0.01
- BGLC -0.04
- Stochastic Oscillator
- PETZ 68.91
- BGLC 25.00
About PETZ TDH Holdings Inc.
TDH Holdings Inc is engaged in the business of manufacturing and selling pet food and restaurant operations. The company has two operating segments, which include Petfood sales and the Restaurant business. It has a focus on the Restaurant business segment and generates the majority of its revenue.
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.